After a brief introduction, medical experts discuss advances in MDS classification and molecular understanding.
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA
Advertisement
Articles by Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
2
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
3
Making the Genetic Models Match the Ancestry of Patient Populations
4
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
5
